Shares of Zynex closed 10.1% higher on Monday after the medical device manufacturer announced its plans to repurchase $10 million worth of shares.
Zynex (ZYXI) said that the repurchase program will commence immediately and is set to expire on Sep. 8, or before the buyback limit of $10 million is reached.
The company’s CEO Thomas Sandgaard said, “this buyback program authorization reflects the board's confidence in both our short-term prospects and our long term growth strategy.” He added that, “the buyback program represents an attractive opportunity to deploy capital in a way that will benefit stockholders.”
Last month, Zynex reported lower-than-expected 4Q results. The company reported 4Q earnings of $0.05 per share, which missed consensus estimates by a cent and fell 44.4% year-over-year. Revenues of $25.6 million grew 81% year-over-year but missed analysts’ expectations of $25.8 million. (See Zynex stock analysis on TipRanks)
Following the 4Q miss, B.Riley Financial analyst Marc Wiesenberger downgraded the stock to Hold from Buy and lowered the price target to $19 (17% upside potential) from $23. In a note to investors, the analyst said that the company provided a “wider than normal” FY21 guidance range. The analyst further lowered his FY21 estimates, given “deteriorating profitability and increased uncertainty.”
Overall, the Street has a Moderate Buy consensus rating based on 1 Buy and 3 Holds. The average analyst price target of $21.63 implies upside potential of over 33% to current levels. Shares have gained about 14.6% in one year.
We believe that there are several stocks in the transportation sector that are better than Union Pacific (NYSE:UNP). Union Pacific’s current market cap-to-operating income ratio of 18x compares with 12x for U.S. Xpress Enterprises (USX), 14x for Werner Enterprises (WERN),
Our indicative theme of Gene Editing stocks is down by about 24% year-to-date, compared to the S&P 500 which has remained almost flat over the same period. The recent sell-off comes on the back of rising bond yields, which have caused investors to rotate out of technology a
Sirius XM’s stock (NASDAQ: SIRI) has declined only slightly over the last five days to levels of around $6 currently. But will the company’s stock see higher levels over the coming weeks, or is a further decline in the stock imminent? According to the Trefis Machine
The stock price of FibroGen (NASDAQ: FGEN), a biopharmaceutical company focused on therapeutics in immunology and oncology, has seen a large 36% drop over the last ten trading days, while it’s down 32% over the last five trading days, but we believe the stock, after
The stock price of Walgreens Boots Alliance (NYSE:WBA) looks attractive at current levels of $47, as it is up a mere 7% from the levels it was on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks a significant underperformance com
Tapestry’s (NYSE: TPR) stock, a luxury goods retailer of handbags, shoes, and accessories under the Coach, Kate Spade, and Stuart Weitzman has increased by almost 22% over the last month (twenty-one trading days) and currently stands at around $41. The market reacted upwa
Bed Bath & Beyond stock (NASDAQ: BBBY), a home goods retailer, saw its revenue decline 14% to a consolidated figure of $9.7 Bil for the last 4 quarters from the consolidated figure of $11.34 Bil for the 4-quarter period before that. Despite this, BBBY stock has gained a who
Whirlpool’s stock (NYSE: WHR), a manufacturer and marketer of major home appliances, is about 2.8x higher than the levels on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This compares with a 68% rise for the S&P over the same perio
Best Tech Stocks To Watch Right Now Amid The DipTech stocks continue their bumpy ride for the sixth week. Rising Treasury yields have brought renewed pressure to equities with lofty valuations. Given how President Biden’s $1.9 trillion coronavirus relief plan was approved i
Casey's General Stores (CASY) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.91 per share a year ago. These figures are adjusted for non-recurring items.
Si-Bone (SIBN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss of $0.36 per share a year ago. These figures are adjusted for non-recurring items.
A tie-up between leasing giants AerCap and General Electric unit GECAS would reshape global air finance and carve out a new chapter in one of Ireland's greatest corporate adventures.
Penn Virginia (PVAC) came out with quarterly earnings of $1.43 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $2.75 per share a year ago. These figures are adjusted for non-recurring items.
Trecora (TREC) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.03 per share a year ago. These figures are adjusted for non-recurring items.
Capitala Finance (CPTA) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.29. This compares to earnings of $0.72 per share a year ago. These figures are adjusted for non-recurring items.
Harrow Health (HROW) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.
In trading on Monday, shares of So-Young International Inc (Symbol: SY) crossed below their 200 day moving average of $12.51, changing hands as low as $12.01 per share. So-Young International Inc shares are currently trading off about 12.5% on the day. The chart below shows t